Results 321 to 330 of about 2,574,537 (354)
Some of the next articles are maybe not open access.
Central administration of perfluorooctanoic acid inhibits cutaneous inflammation
Inflammation Research, 2005To elucidate the site of action of perfluorooctanoic acid (PFOA) in the carrageenan model of peripheral inflammation.Male Sprague-Dawley rats.We first compared the anti-edema effects of systemic PFOA (50-150 mg/kg) with prototypical nonsteroidal (acetylsalicylic acid, ASA, 50-200 mg/kg) and steroidal (dexamethasone, 0.5-5.0 mg/kg) drugs after the ...
B K, Taylor +4 more
openaire +2 more sources
Levodopa Administration and Multiple Primary Cutaneous Melanomas
Archives of Dermatology, 1980• Malignant melanoma derives from melanocytic cells that possess the special biochemical pathway for the conversion of levodopa to melanin. Levodopa is widely employed in the treatment of Parkinson's disease, and several patients receiving levodopa have been observed to have acquired melanomas, raising concern about a possible relationship between this
J E, Bernstein +4 more
openaire +3 more sources
Cutaneous Atrophy Secondary to Intra-articular Corticosteroid Administration
Annals of Internal Medicine, 1966Excerpt Intra-articular injection of adrenocorticosteroid has been shown to be a useful therapeutic procedure in the management of patients with rheumatoid arthritis.
J T, Cassidy, G G, Bole
openaire +2 more sources
Hepatotoxicity and cutaneous reactions after antithyroid drug administration
Clinical Endocrinology, 2012SummaryObjectiveUse of the antithyroid drugs (ATDs) thiamazole (MMI) and propylthiouracil (PTU) is associated with a high frequency of side effects. When patients experience side effects with one (the 1st) ATD, it is usually discontinued and another is administered (the 2nd ATD).
Fumiko, Otsuka +7 more
openaire +2 more sources
Cutaneous reactions to adalimumab administration.
Irish medical journal, 2011Patients receiving antitumour necrosis factor-alpha treatment may develop cutaneous reactions. This human monoclonal antibody is used in the treatment of chronic inflammatory diseases, including arthritis and inflammatory bowel disease. A variety of side effects have been documented ranging from infection and vasculitis through to systemic lupus ...
M R, Downes +4 more
openaire +3 more sources
Cutaneous calcinosis-an unusual complication of intravenous phosphate administration
Clinical and Experimental Dermatology, 1993The case of an 80-year-old woman who developed extensive cutaneous calcification following intravenous phosphate administration is presented. Also the circumstances under which cutaneous calcification may occur are discussed.
C M, Mills, A G, Knight
openaire +2 more sources
Cutaneous Lesion Induced by a Subcutaneous Administration of Bortezomib
Clinical Lymphoma Myeloma and Leukemia, 2012Introduction A 78-year-old man presented to our hospital with an indurated, painful lesion on the abdominal wall at the site of a recent subcutaneous (SC) bortezomib injection. The patient was diagnosed with multiple myeloma (MM) in 2007 after a bone marrow biopsy was done as part of anemia workup.
Karam M, Obeid +2 more
openaire +2 more sources
Journal of the American Academy of Dermatology, 1985
The fixed cutaneous type of sporotrichosis is difficult to diagnose because clinical lesions are variable in appearance and the cells of Sporothrix schenckii are usually scarce in skin biopsy specimens. We have described two patients with lesions of fixed cutaneous sporotrichosis that resembled other inflammatory skin conditions and were treated with ...
L K, Bickley, I J, Berman, A F, Hood
openaire +2 more sources
The fixed cutaneous type of sporotrichosis is difficult to diagnose because clinical lesions are variable in appearance and the cells of Sporothrix schenckii are usually scarce in skin biopsy specimens. We have described two patients with lesions of fixed cutaneous sporotrichosis that resembled other inflammatory skin conditions and were treated with ...
L K, Bickley, I J, Berman, A F, Hood
openaire +2 more sources
Selective cutaneous hyperpigmentation in mice following zidovudine administration.
Archives of dermatology, 1992C57BL/6N mice fed zidovudine in their drinking water develop selective hyperpigmentation of the tails and footpads. Zidovudine-fed and identical control mice were observed and sequential biopsy specimens were obtained. Routine light microscopy, electron microscopy, and image analysis of unstained biopsy specimens were used to evaluate the extent ...
M L, Obuch +5 more
openaire +3 more sources
Cutaneous blood flow and local sweating after systemic atropine administration
Pflügers Archiv - European Journal of Physiology, 1987Localized cutaneous vasodilation (flush) is seen following systemic atropine administration. To verify calculated enhanced dry heat loss with actual changes in cutaneous blood flow, four men were studied in both control and atropine (0.025 mg.kg-1; im) experiments (Ta = 30 degrees C, Tdp = 7 degrees C) during moderate exercise (55% VO2 peak ...
M A, Kolka, L A, Stephenson
openaire +2 more sources